Biosimilars market: Would it help you to know the high risk areas when entering the biosimilars market? Do you want to know key strategic considerations the industry are looking at before they make the move into biosimilars?
They responded with these top 4 answers below:
- Regulatory environment
- Intellectual property
- Clinical development
Do these match with your company's priorities or would you like to put another driver into the mix? Let us know by commenting below!
Interested in reading more on this topic?Â Take a look here: Top drivers fuelling industries biosimilar engagement today
For more updates on pharma, biotech and R&D, follow us on Twitter: @biopharmaevents or join our LinkedIn group: BioPharma- Networking for Pharmaceuticals, Biotech and R&D